Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 12
Submit an article Journal homepage
5,871
Views
9
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Relationship of response and survival in patients with relapsed and refractory multiple myeloma treated with pomalidomide plus low-dose dexamethasone in the MM-003 trial randomized phase III trial (NIMBUS)

Philippe MoreauHematology Department, University Hospital Hôtel-Dieu, Nantes, France; Correspondence[email protected]
,
Katja C. WeiselUniversity of Tübingen, Tübingen, Germany;
,
Kevin W. SongVancouver General Hospital, Vancouver, BC, Canada;
,
Craig J. GibsonCelgene Corporation, Summit, NJ, USA;
,
Owain SaundersBresMed Health Solutions, Sheffield, UK;
,
Lars Axel SternasCelgene Corporation, Summit, NJ, USA;
,
Kevin HongCelgene Corporation, Summit, NJ, USA;
,
Mohamed H. ZakiCelgene Corporation, Summit, NJ, USA;
&
Meletios A. DimopoulosAlexandra Hospital, Athens, Greece
 show all
Pages 2839-2847 | Received 15 Jan 2016, Accepted 13 Apr 2016, Published online: 13 May 2016

Reprints and Permissions

Taylor & Francis does not sell reprints or permissions for this article. Please refer to the 'Licensing' tab on the article menu bar for information on the reuse conditions associated with this license type.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.